Mil Familias-Santa Barbara's Operational Pilot to Understand Diabetes in the Latino Community
MilFamilias
Mil Familias- Santa Barbara Operational Pilot
1 other identifier
observational
100
1 country
1
Brief Summary
The Mil Familias Program is a 10-year initiative to reduce the burden of cardio-metabolic disease among Latino families in the Central Coast of California. The Mil Familias Program involves enrolling 1000 Latino families with at least one member in the family having type 2 diabetes, measuring the 5 determinants of human health: genetics, biology, behavior, psychology and environment, training Latino community health workers ("Especialistas") , creating a Living Information (bio)Bank and planning culturally-relevant interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 24, 2017
CompletedFirst Submitted
Initial submission to the registry
October 30, 2018
CompletedFirst Posted
Study publicly available on registry
November 9, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedJanuary 9, 2019
January 1, 2019
1.4 years
October 30, 2018
January 8, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Success (evaluated by Yes/No format) recruiting and establishing a pilot cohort of 100 Latino adults with Type 2 Diabetes and creating data collection methods to describe genetics, biology, behavior, psychology, & environment in Type 2 Diabetes
Mil Familias Program Pilot will measure genetic influences by a family medical history \& biobank blood samples. Biologic influences will include laboratory blood draw, physical exam with vital signs \& waist circumference measurement, and complete medical \& medication history with female menopause, pregnancy, \& gestational diabetes status. Behavior influences will include sleep, stress, drug abuse, and diabetes self-assessment management questionnaires. Wearable devices will measure physical activity. Psychological influences will include Patient Health Questionnaire-9, Brief Perceived Ethnic Discrimination Questionnaire Community Version, and Short Form Health Survey. Social/environmental influences will include socio-demographics, Brief Acculturation Scale for Hispanics, personal opinions about type 2 diabetes, and questionnaires \[Short Assessment of Health Literacy, Trust in Physician, Health Leads Screening Toolkit, and U.S. Household Food Security Survey\].
1 year
Secondary Outcomes (22)
Socio-demographics measured by questionnaire - including age, gender, race/ethnicity, contact information, number in household, income, education, marital status, occupation, insurance status, immigration status, alcohol & tobacco use, and birth place
Beginning of study - Baseline visit 1
Self-assessment of diabetes management measured by the American Diabetes Association questionnaire, Participant Self-Assessment of Diabetes Management
Beginning of study - Baseline visit 1
Food security assessed by U.S. Household Food Security Survey Module: Six-item short form
Beginning of study - Baseline visit 1
Social needs screening assessed by the Health Leads Screening Toolkit
Beginning of study - Baseline visit 1
Number of visits to a healthcare provider in the last year and difficulty in traveling to a healthcare provider measured by electronic medical record and interview
Beginning of study - Baseline visit 1
- +17 more secondary outcomes
Other Outcomes (2)
Engagement of a local consortium of partners to implement participant recruitment; data collection, storage, and analysis; healthcare access; and/or intervention measured by the number of major operational partnerships with formal agreements
1 year
Success measured by the number of health care workers trained, upskilled, and employed to be community health care workers (Especialistas) and the number of participant encounters with a trained health care worker
1 year
Study Arms (1)
Type 2 Diabetes
Male and female adults of Hispanic and/or Latino heritage with an established diagnosis of Type 2 diabetes.
Eligibility Criteria
Up to 125 individuals may be screened and enrolled with the prediction of 20% screen-fail or dropout and 100 people completing SB1K Phase I.
You may qualify if:
- Males or females ≥ 18 years of age at Visit 1 (screening and enrollment).
- Self-reported Hispanic and/or Latino heritage.
- Currently residing in Santa Barbara County, California.
- Established diagnosis of Type 2 diabetes for at least one year prior to enrollment date.
- Signed and dated written informed consent by the date of Visit 1.
- Based on the research staff's judgment, subject must have a good understanding, ability, and willingness to adhere to the protocol, including performance of self-monitored data collection during the wearable device portion.
You may not qualify if:
- Diagnosed severe cardiovascular disease, within the 6 months prior to enrollment Visit 1, defined as: previous stroke; decompensated heart failure New York Heart Association class III or IV; myocardial infarction; unstable angina pectoris; or coronary arterial bypass graft or angioplasty.
- Life expectancy \< 2 years.
- Any active clinically significant disease or disorder, which in the investigator's opinion could interfere with the participation of the trial.
- Mental incapacity, psychiatric disorder, unwillingness or language barriers precluding comprehension of study activities and informed consent.
- Participation in other trials involving medication or device within 1 month prior to Visit 1.
- Known or suspected abuse of alcohol, narcotics, or illicit drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sansum Diabetes Research Institutelead
- Eli Lilly and Companycollaborator
Study Sites (1)
Sansum Diabetes Research Institute
Santa Barbara, California, 93105, United States
Related Publications (2)
Glantz NM, Morales JM, Bevier WC, Larez A, Hoppe CB, Duncan I, Mackenzie A, Kerr D. Insurance Status and Biological and Psychosocial Determinants of Cardiometabolic Risk Among Mexican-Origin U.S. Hispanic/Latino Adults with Type 2 Diabetes. Health Equity. 2020 May 4;4(1):142-149. doi: 10.1089/heq.2019.0119. eCollection 2020.
PMID: 32440613DERIVEDBevier W, Glantz N, Hoppe C, Morales Glass J, Larez A, Chen K, Kerr D. Self-reported and objectively measured physical activity levels among Hispanic/Latino adults with type 2 diabetes. BMJ Open Diabetes Res Care. 2020 Mar;8(1):e000893. doi: 10.1136/bmjdrc-2019-000893.
PMID: 32169933DERIVED
Biospecimen
Serum, Plasma, Buffy coat (white cells)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Kerr, M.D.
Sansum Diabetes Research Institute
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 30, 2018
First Posted
November 9, 2018
Study Start
August 24, 2017
Primary Completion
December 31, 2018
Study Completion
December 31, 2018
Last Updated
January 9, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- Data will be made available after the primary publication of each analysis.
- Access Criteria
- Data Sharing Agreements will be formulated by a committee of study investigators and community and industry partners.
All individual participant data (IPD) that underlie results in publications.